Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD?
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 12034804.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Polymorphisms in the interleukin-1 genes, IL-1A and IL-1B, have been associated with AD, but not in all studies. The authors genotyped the IL-1A(-889) and IL-1B(-511) polymorphisms in large independent cohorts of 503 control individuals and 395 patients with AD, and a further 100 with brain Abeta load. No evidence was found of risk for AD with these variants, nor of an effect on age at onset. However, an impact of IL-1B(-511) on Abeta(40) load (p < 0.05) was detected.
Medical subject headings
- Alzheimer Disease
- Interleukin-1
- Polymorphism, Genetic